Scientists hunt for clues in the brain to unlock future treatments for rare movement disorders
NCT ID NCT04288128
Summary
This study aimed to find better ways to measure the progression of two rare, inherited brain diseases called Spinocerebellar Ataxia Type 2 and Type 7. Researchers followed 40 people with these conditions for one year, using brain scans, blood tests, and movement assessments. The goal was to identify precise 'biomarkers' to help test future experimental drugs more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut du Cerveau - Paris Brain Institute
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.